Sailong Pharmaceutical Group Co., Ltd. Profile Avatar - Palmy Investing

Sailong Pharmaceutical Group Co., Ltd.

Sailong Pharmaceutical Group Co., Ltd. researches, develops, produces, markets, and services pharmaceutical intermediates, raw materials, and preparations in China. The company offers esomeprazole sodium, ornithine aspartate, thymus, argatroban, gaicycli…

Biotechnology
CN, Zhuhai [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Sailong Pharmaceutical Group Co., Ltd. can't present it's latest revenue by geo. area

Historical Revenue By Segment

Last 3Y, in mil. USD

Sailong Pharmaceutical Group Co., Ltd. can't present revenue by segment

End of 002898.SZ's Analysis
CIK: - CUSIP: - ISIN: CNE1000032S5 LEI: - UEI: -
Secondary Listings
002898.SZ has no secondary listings inside our databases.